kabutan

M3, Inc.(2413) Summary

2413
TSE Prime
M3, Inc.
2,072.0
JPY
-7.0
(-0.34%)
Dec 12, 3:30 pm JST
13.29
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
2,077
Dec 12, 11:57 pm JST
Summary Chart Historical News Financial Result
PER
31.2
PBR
3.62
Yield
ー%
Margin Trading Ratio
13.36
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
2,078.5 JPY 13.36 USD
Previous Close Dec 11
2,079.0 JPY 13.31 USD
High Dec 12, 9:05 am
2,090.0 JPY 13.43 USD
Low Dec 12, 10:27 am
2,050.0 JPY 13.16 USD
Volume
4,526,500
Trading Value
9.38B JPY 0.06B USD
VWAP
2072.54 JPY 13.3 USD
Minimum Trading Value
207,200 JPY 1,329 USD
Market Cap
1.41T JPY 9.08B USD
Number of Trades
7,469
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
8,399
1-Year High Aug 7, 2025
48,319
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 299,000 2,236,600 7.48
Nov 28, 2025 351,200 1,736,700 4.95
Nov 21, 2025 464,700 1,699,500 3.66
Nov 14, 2025 526,200 1,867,000 3.55
Nov 7, 2025 270,100 2,281,700 8.45
Company Profile
M3, Inc. is a Sony Group affiliate specializing in pharmaceutical marketing support. It provides information through a website for physicians and is also involved in telemedicine.
Sector
Services
M3, Inc., a member of the Sony Group, aims to revolutionize the medical world through the use of the internet. The company operates various services both domestically and internationally, centered around its professional medical website "m3.com". Its main business activities include marketing support for medical-related companies, surveys targeting healthcare professionals, practice management services, clinical trial support, CSO operations, and the development and sale of electronic medical records. M3 also engages in evidence solution services such as clinical development support, clinical trial management and operational support, and subject recruitment assistance. Additionally, the company provides human resource services for medical professionals, management support for medical institutions, and operates hospice facilities. Internationally, M3 has expanded its operations globally, offering marketing support, surveys, human resource services for medical professionals, and clinical trial support.